Arcadia Biosciences (RKDA) Stock Statistics & Valuation Metrics

Arcadia Biosciences has a market cap or net worth of $4.83M. The enterprise value is $1.46M.

Arcadia Biosciences has 1,367,040 shares outstanding. The number of shares has decreased by -2.65% in one year.

Arcadia Biosciences’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -32.45%.

The current PE Ratio of Arcadia Biosciences is ―. Arcadia Biosciences’s PEG ratio is 0.02.

In the last 12 months, Arcadia Biosciences had revenue of 5.04M and earned -7.04M in profits. Earnings per share was -5.16.

In the last 12 months, operating cash flow was -6.09M and capital expenditures 0.00, giving a free cash flow of -6.09M billion.

Arcadia Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Arcadia Biosciences upcoming earnings date is Apr 1, 2026, After Close (Confirmed).

Arcadia Biosciences as a current ratio of 3.61, with Debt / Equity ratio of 0.24%

In the past 12 months, Arcadia Biosciences has paid 8.00K in taxes.

Arcadia Biosciences EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.41.

Arcadia Biosciences has $5.88M in cash and marketable securities with $0.00 in debt, giving a net cash position of $5.88M billion.

Gross margin is 37.78%, with operating margin of -72.31%, and net profit margin of -139.50%.

The average price target for Arcadia Biosciences is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy